OPNT Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Mar 2023 @ 16:00):

Stats
Today's Volume	562 778
Average Volume	72 355.00
Market Cap	108.80M
EPS	$0.110 ( 2023-03-21 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.16
ATR14	$0.278 (1.35%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-02	Silver Gabrielle Alison	Sell	21 343	Common Stock
2023-03-02	Silver Gabrielle Alison	Sell	2 500	Stock Option (right to buy)
2023-03-02	Silver Gabrielle Alison	Sell	2 000	Common Stock
2023-03-02	Silver Gabrielle Alison	Sell	2 500	Common Stock
2023-03-02	Silver Gabrielle Alison	Sell	2 500	Stock Option (right to buy)

INSIDER POWER
-97.63
Last 100 transactions
Buy: 31 334 \| Sell: 1 708 118

Volume Correlation

Long: 0.22 (neutral)

Short: -0.75 (moderate negative)

Signal:(50.127) Neutral

Opiant Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Opiant Pharmaceuticals Correlation - Currency/Commodity

0.76
( moderate )

0.81
( strong )

-0.31
( neutral )

0.51
( weak )

-0.31
( neutral )

0.26
( neutral )

Opiant Pharmaceuticals Financials

Annual	2021
Revenue:	$40.73M
Gross Profit:	$31.66M (77.74 %)
EPS:	$0.680

Q3	2022
Revenue:	$173.87M
Gross Profit:	$173.87M (100.00 %)
EPS:	$-1.930

Q2	2022
Revenue:	$2.33M
Gross Profit:	$1.81M (77.78 %)
EPS:	$-2.31

Q1	2022
Revenue:	$2.19M
Gross Profit:	$1.77M (80.56 %)
EPS:	$-2.51

Financial Reports:

No articles found.

Opiant Pharmaceuticals

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.